Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: Efficacies and mechanisms
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: Efficacies and mechanisms
Authors
Keywords
Traditional Chinese Medicine (TCM), Viral infections, COVID-19, Jinhua Qinggan granules (JHQG), Lianhua Qingwen capsules (LHQW), Lung Cleansing and Detoxifying Decoction (LCDD), Xuanfeibaidu granules (XFBD), Huashibaidu granules (HSBD), Xuebijing (XBJ), Angiotensin converting enzyme 2 (ACE2), Coronavirus 3-chymotrypsin-like protease (3CL, ), Interleukin-6 (IL-6)
Journal
PHARMACOLOGY & THERAPEUTICS
Volume 225, Issue -, Pages 107843
Publisher
Elsevier BV
Online
2021-04-01
DOI
10.1016/j.pharmthera.2021.107843
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro
- (2021) Hongbo Liu et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs
- (2020) Hui Luo et al. Chinese Journal of Integrative Medicine
- Traditional Chinese Medicine for COVID-19 Treatment
- (2020) Jun-ling Ren et al. PHARMACOLOGICAL RESEARCH
- Is traditional Chinese medicine useful in the treatment of COVID-19?
- (2020) Kai Zhang AMERICAN JOURNAL OF EMERGENCY MEDICINE
- Protection against COVID-19 injury by Qingfei Paidu decoction via anti-viral, anti-inflammatory activity and metabolic programming
- (2020) Jian Chen et al. BIOMEDICINE & PHARMACOTHERAPY
- Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
- (2020) Vanessa Monteil et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7)
- (2020) CHINESE MEDICAL JOURNAL
- IL-6 may be a good biomarker for earlier detection of COVID-19 progression
- (2020) Changsong Wang et al. INTENSIVE CARE MEDICINE
- Shegan-Mahuang Decoction ameliorates asthmatic airway hyperresponsiveness by downregulating Th2/Th17 cells but upregulating CD4+FoxP3+ Tregs
- (2020) Cheng-Chuang Lin et al. JOURNAL OF ETHNOPHARMACOLOGY
- Viral and host factors related to the clinical outcome of COVID-19
- (2020) Xiaonan Zhang et al. NATURE
- Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
- (2020) Jun Lan et al. NATURE
- Cytokine release syndrome in severe COVID-19
- (2020) John B. Moore et al. SCIENCE
- Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
- (2020) Wenhao Dai et al. SCIENCE
- Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
- (2020) Linlin Zhang et al. SCIENCE
- The potential insights of Traditional Chinese Medicine on treatment of COVID-19
- (2020) Tong Tong et al. Chinese Medicine
- Identification of a Pharmacological Biomarker for the Bioassay-Based Quality Control of a Thirteen-Component TCM Formula (Lianhua Qingwen) Used in Treating Influenza A Virus (H1N1) Infection
- (2020) Dan Gao et al. Frontiers in Pharmacology
- Overview of therapeutic drug research for COVID-19 in China
- (2020) Heng Li et al. ACTA PHARMACOLOGICA SINICA
- Treatment strategies of hospitalized patients with coronavirus disease-19
- (2020) Yaxiong Huang et al. Aging-US
- The important role of polysaccharides from a traditional Chinese medicine-Lung Cleansing and Detoxifying Decoction against the COVID-19 pandemic
- (2020) Peng Cao et al. CARBOHYDRATE POLYMERS
- Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Huashi Baidu formula in the treatment of COVID-19
- (2020) Quyuan Tao et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Lianhua-Qingwen Displays Antiviral and Anti-Inflammatory Activity and Synergistic Effects with Oseltamivir against Influenza B Virus Infection in the Mouse Model
- (2020) Chunguang Yang et al. Evidence-based Complementary and Alternative Medicine
- COVID-19 treatment: close to a cure? A rapid review of pharmacotherapies for the novel coronavirus (SARS-CoV-2)
- (2020) Yang Song et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Homology modeling and in silico design of novel and potential dual-acting inhibitors of human histone deacetylases HDAC5 and HDAC9 isozymes
- (2020) Ammar D. Elmezayen et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Comprehensive molecular profiling of intrahepatic cholangiocarcinoma in the Chinese population and therapeutic experience
- (2020) Longrong Wang et al. Journal of Translational Medicine
- Chemical composition and pharmacological mechanism of Qingfei Paidu Decoction and Ma Xing Shi Gan Decoction against Coronavirus Disease 2019 (COVID-19): In silico and experimental study
- (2020) Ruocong Yang et al. PHARMACOLOGICAL RESEARCH
- Efficacy of Huoxiang Zhengqi dropping pills and Lianhua Qingwen granules in treatment of COVID-19: A randomized controlled trial
- (2020) Mingzhong Xiao et al. PHARMACOLOGICAL RESEARCH
- Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)
- (2020) Li Runfeng et al. PHARMACOLOGICAL RESEARCH
- Is a “Cytokine Storm” Relevant to COVID-19?
- (2020) Pratik Sinha et al. JAMA Internal Medicine
- The role played by traditional Chinese medicine in preventing and treating COVID-19 in China
- (2020) Qingwei Li et al. Frontiers of Medicine
- Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy
- (2020) Vincenzo Montesarchio et al. Journal for ImmunoTherapy of Cancer
- Bioactive natural compounds against human coronaviruses: a review and perspective
- (2020) Yanfang Xian et al. Acta Pharmaceutica Sinica B
- Efficacy of herbal medicine (Xuanfei Baidu decoction) combined with conventional drug in treating COVID-19:A pilot randomized clinical trial
- (2020) Wu-zhong Xiong et al. Integrative Medicine Research
- Herbal medicine and pattern identification for treating COVID-19: a rapid review of guidelines
- (2020) Lin Ang et al. Integrative Medicine Research
- Clinical retrospective study on the efficacy of Qingfei Paidu decoction combined with Western medicine for COVID-19 treatment
- (2020) Siyi Xin et al. BIOMEDICINE & PHARMACOTHERAPY
- Cytokine Storms in Cancer and COVID-19
- (2020) Casmir Turnquist et al. CANCER CELL
- Efficacy of Lianhua Qingwen Compared with Conventional Drugs in the Treatment of Common Pneumonia and COVID-19 Pneumonia: A Meta-Analysis
- (2020) Caiyun Hu et al. Evidence-based Complementary and Alternative Medicine
- Evidence-Based Complementary and Alternative Medicine Exploring Active Components and Mechanism of Jinhua Qinggan Granules in Treatment of COVID-19 Based on Virus-Host Interaction
- (2020) Yan Ren et al. Natural Product Communications
- The study on the treatment of Xuebijing injection (XBJ) in adults with severe or critical Corona Virus Disease 2019 and the inhibitory effect of XBJ against SARS-CoV-2
- (2020) Qinhai Ma et al. PHARMACOLOGICAL RESEARCH
- Effect of combination antiviral therapy on hematological profiles in 151 adults hospitalized with severe coronavirus disease 2019
- (2020) Xin Li et al. PHARMACOLOGICAL RESEARCH
- Clinical practice guideline on treating influenza in adult patients with Chinese patent medicines
- (2020) Lei Wu et al. PHARMACOLOGICAL RESEARCH
- Efficacy and safety of Chinese herbal medicine versus Lopinavir-Ritonavir in adult patients with coronavirus disease 2019: a non-randomized controlled trial
- (2020) Shi Nannan et al. PHYTOMEDICINE
- Traditional Chinese medicine Lianhua Qingwen treating corona virus disease 2019(COVID-19): Meta-analysis of randomized controlled trials
- (2020) Mengjie Zeng et al. PLoS One
- Potential drugs for the treatment of the novel coronavirus pneumonia (COVID-19) in China
- (2020) Xiaoqi Pan et al. VIRUS RESEARCH
- Reflections on treatment of COVID-19 with traditional Chinese medicine
- (2020) Hua Luo et al. Chinese Medicine
- Xuebijing injection in the treatment of COVID-19: a retrospective case-control study
- (2020) Hu Guo et al. Annals of Palliative Medicine
- Protocol for developing clinical practice guidelines on traditional Chinese medicine therapy for influenza
- (2020) Guozhen Zhao et al. Annals of Palliative Medicine
- XueBiJing Injection Versus Placebo for Critically Ill Patients With Severe Community-Acquired Pneumonia
- (2019) Yuanlin Song et al. CRITICAL CARE MEDICINE
- Anti-sepsis protection of Xuebijing injection is mediated by differential regulation of pro- and anti-inflammatory Th17 and T regulatory cells in a murine model of polymicrobial sepsis
- (2018) Xi Chen et al. JOURNAL OF ETHNOPHARMACOLOGY
- Curative efficacy and safety of traditional Chinese medicine xuebijing injections combined with ulinastatin for treating sepsis in the Chinese population
- (2018) Shi-Hui Xiao et al. MEDICINE
- Efficacy and safety of traditional Chinese medicine for the treatment of influenza A (H1N1): A meta-analysis
- (2016) Jiang-Hong Li et al. Journal of the Chinese Medical Association
- A network analysis of the Chinese medicine Lianhua-Qingwen formula to identify its main effective components
- (2016) Chun-Hua Wang et al. Molecular BioSystems
- BATMAN-TCM: a Bioinformatics Analysis Tool for Molecular mechANism of Traditional Chinese Medicine
- (2016) Zhongyang Liu et al. Scientific Reports
- Wuling San protects kidney dysfunction by inhibiting renal TLR4/MyD88 signaling and NLRP3 inflammasome activation in high fructose-induced hyperuricemic mice
- (2015) Ying Yang et al. JOURNAL OF ETHNOPHARMACOLOGY
- Efficacy of Xuebijing for coagulopathy in patients with sepsis
- (2015) Si-Yuan Hou et al. SAUDI MEDICAL JOURNAL
- Qualitative and Quantitative Analysis of the Major Constituents in Chinese Medical Preparation Lianhua-Qingwen Capsule by UPLC-DAD-QTOF-MS
- (2015) Weina Jia et al. TheScientificWorldJOURNAL
- Qualitative and Quantitative Analysis of the Major Constituents in Chinese Medical Preparation Lianhua-Qingwen Capsule by UPLC-DAD-QTOF-MS
- (2015) Weina Jia et al. Scientific World Journal
- Treatment Effects of Xuebijing Injection in Severe Septic Patients with Disseminated Intravascular Coagulation
- (2014) Qin Yin et al. Evidence-based Complementary and Alternative Medicine
- TCMSP: a database of systems pharmacology for drug discovery from herbal medicines
- (2014) Jinlong Ru et al. Journal of Cheminformatics
- Oseltamivir Compared With the Chinese Traditional Therapy Maxingshigan–Yinqiaosan in the Treatment of H1N1 Influenza
- (2013) Chen Wang et al. ANNALS OF INTERNAL MEDICINE
- Current Understanding on Antihepatocarcinoma Effects of Xiao Chai Hu Tang and Its Constituents
- (2013) Ningning Zheng et al. Evidence-based Complementary and Alternative Medicine
- Mechanism by which ma-xing-shi-gan-tang inhibits the entry of influenza virus
- (2012) Chung-Fan Hsieh et al. JOURNAL OF ETHNOPHARMACOLOGY
- TCMID: traditional Chinese medicine integrative database for herb molecular mechanism analysis
- (2012) Ruichao Xue et al. NUCLEIC ACIDS RESEARCH
- Anti-influenza agents from Traditional Chinese Medicine
- (2010) Hu Ge et al. NATURAL PRODUCT REPORTS
- ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks
- (2009) Gabriela Bindea et al. BIOINFORMATICS
- The Yellow Emperor’s Classic of Internal Medicine
- (2008) James Curran BMJ-British Medical Journal
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started